| 000 | 01344 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513211400.0 | ||
| 264 | 0 | _c20000616 | |
| 008 | 200006s 0 0 ita d | ||
| 022 | _a1129-4728 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aModena, M G | |
| 245 | 0 | 0 |
_a[Use of estrogen-progestins in secondary prevention]. _h[electronic resource] |
| 260 |
_bItalian heart journal. Supplement : official journal of the Italian Federation of Cardiology _cMar 2000 |
||
| 300 |
_a435-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCoronary Disease _xprevention & control |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEstrogen Replacement Therapy _xadverse effects |
| 650 | 0 | 4 |
_aEstrogens, Conjugated (USP) _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMedroxyprogesterone Acetate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProgesterone Congeners _xadministration & dosage |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aOrigliani, G | |
| 700 | 1 | _aRossi, R | |
| 773 | 0 |
_tItalian heart journal. Supplement : official journal of the Italian Federation of Cardiology _gvol. 1 _gno. 3 _gp. 435-6 |
|
| 999 |
_c10767013 _d10767013 |
||